Cargando…
Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)
This joint report from the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) aims for a consensus around the scientific rationale and clinical strategy for the management of osteoporotic patients affected by periodontitis who ar...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349795/ https://www.ncbi.nlm.nih.gov/pubmed/37453950 http://dx.doi.org/10.1186/s10195-023-00713-7 |
_version_ | 1785073996988940288 |
---|---|
author | Landi, L. Leali, P. Tranquilli Barbato, L. Carrassi, A. M. Discepoli, N. Muti, P. C. M. Oteri, G. Rigoni, M. Romanini, E. Ruggiero, C. Tarantino, U. Varoni, E. Sforza, N. M. Brandi, M. L. |
author_facet | Landi, L. Leali, P. Tranquilli Barbato, L. Carrassi, A. M. Discepoli, N. Muti, P. C. M. Oteri, G. Rigoni, M. Romanini, E. Ruggiero, C. Tarantino, U. Varoni, E. Sforza, N. M. Brandi, M. L. |
author_sort | Landi, L. |
collection | PubMed |
description | This joint report from the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) aims for a consensus around the scientific rationale and clinical strategy for the management of osteoporotic patients affected by periodontitis who are undergoing anti-resorptive (AR) therapy to manage the risk of the occurrence of a medication-related osteonecrosis of the jaws (MRONJ). Osteoporosis and periodontitis are chronic diseases with a high prevalence in aging patients, and they share some of the same pathogenetic mechanisms based upon inflammation. Available evidence shows the relationship among osteoporosis, AR agents, periodontitis and implant therapy in relation to the incidence of MRONJ. Uncontrolled periodontitis may lead to tooth loss and to the need to replace teeth with dental implants. Tooth extraction and surgical dental procedures are recognized as the main risk factors for developing MRONJ in individuals taking AR therapy for osteometabolic conditions. Although the incidence of MRONJ in osteometabolic patients taking AR therapy may be as low as 0.9%, the increasing prevalence of osteoporosis and the high prevalence of periodontitis suggest that this potential complication should not be overlooked. Good clinical practice (GCP) guidelines are proposed that aim at a more integrated approach (prescriber, dentist, periodontist and dental hygienist) in the management of periodontitis patients undergoing AR therapy for osteometabolic disorders to reduce the risk of MRONJ. Dental professional and prescribers should educate patients regarding the potential risk associated with the long-term use of AR therapy and oral health behavior. |
format | Online Article Text |
id | pubmed-10349795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-103497952023-07-17 Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) Landi, L. Leali, P. Tranquilli Barbato, L. Carrassi, A. M. Discepoli, N. Muti, P. C. M. Oteri, G. Rigoni, M. Romanini, E. Ruggiero, C. Tarantino, U. Varoni, E. Sforza, N. M. Brandi, M. L. J Orthop Traumatol Review Article This joint report from the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) aims for a consensus around the scientific rationale and clinical strategy for the management of osteoporotic patients affected by periodontitis who are undergoing anti-resorptive (AR) therapy to manage the risk of the occurrence of a medication-related osteonecrosis of the jaws (MRONJ). Osteoporosis and periodontitis are chronic diseases with a high prevalence in aging patients, and they share some of the same pathogenetic mechanisms based upon inflammation. Available evidence shows the relationship among osteoporosis, AR agents, periodontitis and implant therapy in relation to the incidence of MRONJ. Uncontrolled periodontitis may lead to tooth loss and to the need to replace teeth with dental implants. Tooth extraction and surgical dental procedures are recognized as the main risk factors for developing MRONJ in individuals taking AR therapy for osteometabolic conditions. Although the incidence of MRONJ in osteometabolic patients taking AR therapy may be as low as 0.9%, the increasing prevalence of osteoporosis and the high prevalence of periodontitis suggest that this potential complication should not be overlooked. Good clinical practice (GCP) guidelines are proposed that aim at a more integrated approach (prescriber, dentist, periodontist and dental hygienist) in the management of periodontitis patients undergoing AR therapy for osteometabolic disorders to reduce the risk of MRONJ. Dental professional and prescribers should educate patients regarding the potential risk associated with the long-term use of AR therapy and oral health behavior. Springer International Publishing 2023-07-15 2023-12 /pmc/articles/PMC10349795/ /pubmed/37453950 http://dx.doi.org/10.1186/s10195-023-00713-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Landi, L. Leali, P. Tranquilli Barbato, L. Carrassi, A. M. Discepoli, N. Muti, P. C. M. Oteri, G. Rigoni, M. Romanini, E. Ruggiero, C. Tarantino, U. Varoni, E. Sforza, N. M. Brandi, M. L. Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title | Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title_full | Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title_fullStr | Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title_full_unstemmed | Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title_short | Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP) |
title_sort | anti-resorptive therapy in the osteometabolic patient affected by periodontitis. a joint position paper of the italian society of orthopaedics and traumatology (siot) and the italian society of periodontology and implantology (sidp) |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349795/ https://www.ncbi.nlm.nih.gov/pubmed/37453950 http://dx.doi.org/10.1186/s10195-023-00713-7 |
work_keys_str_mv | AT landil antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT lealiptranquilli antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT barbatol antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT carrassiam antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT discepolin antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT mutipcm antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT oterig antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT rigonim antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT romaninie antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT ruggieroc antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT tarantinou antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT varonie antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT sforzanm antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp AT brandiml antiresorptivetherapyintheosteometabolicpatientaffectedbyperiodontitisajointpositionpaperoftheitaliansocietyoforthopaedicsandtraumatologysiotandtheitaliansocietyofperiodontologyandimplantologysidp |